Bio-Rad Laboratories, Inc. BIO.B Other accrued liabilities
Other accrued liabilities at other companies
Other financials
Where this comes from
Reported directly by Bio-Rad Laboratories, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherLiabilitiesCurrent.
The official record: Bio-Rad Laboratories, Inc.’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Bio-Rad Laboratories, Inc.'s other accrued liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Bio-Rad Laboratories, Inc.'s other accrued liabilities?
- Bio-Rad Laboratories, Inc. (BIO.B) reported other accrued liabilities of $153.9M in Q1 2026.
- How has Bio-Rad Laboratories, Inc.'s other accrued liabilities changed year-over-year?
- Bio-Rad Laboratories, Inc.'s other accrued liabilities increased by 16.9% year-over-year, from $131.7M to $153.9M.
- What is the long-term trend for Bio-Rad Laboratories, Inc.'s other accrued liabilities?
- Over 5 years (2020 to 2025), Bio-Rad Laboratories, Inc.'s other accrued liabilities has grown at a 1.6% compound annual growth rate (CAGR), from $131.1M to $141.7M.
- What does other accrued liabilities mean?
- This captures miscellaneous short-term obligations that do not fit into standard categories like accounts payable or accrued compensation. It often includes items such as customer deposits, short-term tax provisions, or other minor contractual liabilities. It provides insight into the breadth of the company's short-term financial commitments.